Aldeyra Therapeutics, Inc. earnings releases ALDX

Annual Quarterly

Aldeyra Therapeutics, Inc. last reported quarterly results on May 4, 2023, for the quarter ended Mar 31, 2023. It usually reports 34–68 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 34–68 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
May 4, 2023 34 days after quarter end	— ended Mar 31, 2023	—	—	—
Mar 9, 2023 68 days after quarter end	— ended Dec 31, 2022	—	—	—
Nov 10, 2022 41 days after quarter end	— ended Sep 30, 2022	—	—	—
Aug 5, 2022 36 days after quarter end	— ended Jun 30, 2022	—	—	—
May 5, 2022 35 days after quarter end	— ended Mar 31, 2022	—	—	—
Oct 28, 2021 28 days after quarter end	— ended Sep 30, 2021	—	—	—
Aug 5, 2021 36 days after quarter end	— ended Jun 30, 2021	—	—	—
May 6, 2021 36 days after quarter end	— ended Mar 31, 2021	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: ALDX (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Concord, MA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1341235
Former names: Aldexa Therapeutics, Inc. (until Mar 4, 2014); Neuron Systems Inc (until Aug 1, 2008)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.